Ying Liang
University of Electronic Science and Technology of China(CN)Sun Yat-sen University(CN)Second Military Medical University(CN)Zhaoqing University(CN)Chinese Academy of Medical Sciences & Peking Union Medical College(CN)Peking University(CN)Fudan University(CN)Kunming Medical University(CN)Taipei Veterans General Hospital(TW)Sun Yat-sen Memorial Hospital(CN)First Affiliated Hospital of Guangzhou Medical University(CN)Changhai Hospital(CN)Sichuan Cancer Hospital(CN)Xiyuan Hospital(CN)Changsha Hospital for Maternal and Child Health Care(CN)Sun Yat-sen University Cancer Center(CN)Tang Du Hospital(CN)National Institute of Mental Health(JP)Peking University Sixth Hospital(CN)First Affiliated Hospital Zhejiang University(CN)National Institute of Mental Health(CZ)Inner Mongolia Medical University(CN)Jiangxi Normal University(CN)Zhejiang University(CN)University of Hong Kong(HK)Guangzhou Medical University(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
RNA modifications and cancer, Cancer-related molecular mechanisms research, Peptidase Inhibition and Analysis, Coenzyme Q10 studies and effects, MicroRNA in disease regulation
Most-Cited Works
- → Activation of DNA Methyltransferase 1 by EBV LMP1 Involves c-Jun NH2-Terminal Kinase Signaling(2006)238 cited
- → Small Cell Carcinoma of the Breast(2000)200 cited
- → Leukemia inhibitory factor promotes nasopharyngeal carcinoma progression and radioresistance(2013)186 cited
- → Tumour inflammasome‐derived IL‐1β recruits neutrophils and improves local recurrence‐free survival in EBV‐induced nasopharyngeal carcinoma(2012)165 cited
- → miR‐144 downregulation increases bladder cancer cell proliferation by targeting EZH2 and regulating Wnt signaling(2013)156 cited
- → Overexpression and elevated serum levels of phosphoglycerate kinase 1 in pancreatic ductal adenocarcinoma(2006)132 cited